Issuer Credit Research

Issuer Flash: Sammaan Capital Limited - FY2026 Results

Issuer Flash: Sammaan Capital Limited - FY2026 Results

Report date: 2026-05-21 Event date: 2026-05-20 Event title: FY2026 Results

1. Flash Conclusion

Sammaan Capital Limited's FY2026 results are, from a credit perspective, an event where "the near-term burden from loss recognition is heavy, but the company may have established a new starting point under IHC support." The company reported a full-year net loss after tax of Rs 7,145 crore and a standalone Q4 FY2026 net loss of Rs 8,101 crore. Q4 included impairment on financial instruments of Rs 2,958 crore and exceptional losses of Rs 6,499 crore, while equity declined from Rs 21,822 crore at FYE2025 to Rs 18,991 crore at FYE2026.

At the same time, on March 31, 2026, the company brought in Avenir Investment RSC Limited of the IHC Group as promoter and received the initial capital infusion of Rs 5,652 crore. According to company disclosure, IHC's current shareholding is 28.5%, rising to 43.5% after warrant conversion. CRISIL, CARE, and ICRA have all updated their domestic long-term ratings to the AA+ level, and expectations of IHC support could improve funding access. However, IHC support is not an explicit guarantee.

As in the issuer_summary prepared on the same date, this Flash views the company as a "sponsor-supported turnaround NBFC."

2. What Was Announced

On May 20, 2026, the company released its Q4 FY2026 and full-year FY2026 results materials. The main figures are as follows.

Metric Q4 FY2026 FY2026 Credit interpretation
Operating revenue Rs 1,762.85 crore Rs 8,166.16 crore Impairment and exceptional losses are the focus, rather than revenue
Finance costs Rs 1,678.56 crore Rs 5,618.36 crore Need to verify improvement in funding costs and refinancing terms
Impairment on financial instruments Rs 2,958.08 crore Rs 3,627.94 crore The scale of clean-up in the legacy loan book is large
Exceptional loss Rs 6,499.17 crore Rs 6,499.17 crore Explained as a clean-up of non-core and legacy loan assets
Net profit/loss after tax Rs -8,101.40 crore Rs -7,144.56 crore Credit-negative in that it materially eroded equity
Restarting-point AUM Not applicable Rs 53,160 crore Post-clean-up balance as defined by the company. Gross NPA ratio and net NPA ratio are described as zero
Equity Not applicable Rs 18,991 crore Down year on year even after the IHC capital infusion
Leverage Not applicable 2.7x Increased from 1.9x at FYE2025

The company's restarting-point AUM of Rs 53,160 crore comprises housing finance of Rs 30,962 crore, secured business loans / loans against property and related assets of Rs 10,592 crore, commercial real estate and project-related exposure of Rs 10,346 crore, and other assets of Rs 1,260 crore. The company describes the gross NPA ratio and net NPA ratio for this AUM as zero, but this is a post-clean-up balance presentation and does not mean there will be no future losses.

3. Credit Read-Through

Credit positives are IHC's capital participation and promoter status, the AA+ updates by the three domestic rating agencies, and the large cash and investment balance. The initial capital infusion, unexercised warrants, and involvement in the board, risk management, and finance functions reinforce market confidence and funding capacity. At FYE2026, cash and cash equivalents of Rs 9,027 crore, other bank balances of Rs 1,933 crore, and investments of Rs 17,518 crore also support short-term liquidity.

The credit negatives are also clear. The FY2026 loss actually eroded equity, and the post-clean-up AUM has only a short operating track record. Commercial real estate and project-related balances account for around 20% of the book and overlap with areas where problems were more likely to emerge in the legacy loan book. In addition, CRAR, Tier 1, detailed ALM, unused bank lines, and the collateral, guarantee, and change-of-control clauses of individual bonds remain unconfirmed.

Therefore, these results should not be read as "fully positive because the bad news has been cleared out." In the near term, the loss and decline in capital are credit-negative. At the same time, the company may have advanced the clean-up of the legacy loan book under IHC support and created a base for growth from FY2027 onward. The assessment from here will depend on whether additional losses stop, whether the company returns to profitability, and whether funding terms actually improve.

4. What To Watch Next

The first item to review is the FY2026 annual report. The key areas to confirm are exceptional losses, changes in expected credit losses, stage-wise loans, write-offs, collateral, capital ratios, ALM, and the difference between standalone and consolidated accounts. In Q1 FY2027, the points to verify are normalisation of credit costs, recovery to profitability, delinquencies in the post-clean-up AUM, and a decline in finance costs.

On funding, the important issue is how the debt-raising limit of up to Rs 10,000 crore approved on May 20, 2026 is executed in terms of tenor, interest rate, collateral, and currency. If the company can raise diversified funding at longer tenors, this would demonstrate the effectiveness of IHC support. If funding is skewed toward short-tenor, high-cost, collateral-heavy borrowing, the effect of the AA+ ratings would be limited.

For IHC support, the items to monitor are warrant conversion, shareholding ratio, board composition, additional capital, and whether any guarantee is provided. At this point, support expectations are strong, but no legal guarantee has been confirmed.

5. Unconfirmed Items

6. Sources